These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10482999)

  • 1. Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions.
    Tarella C; Corradini P; Astolfi M; Bondesan P; Caracciolo D; Cherasco C; Ladetto M; Giaretta F; Ricca I; Vitolo U; Pileri A; Ferrero D
    Leukemia; 1999 Sep; 13(9):1456-62. PubMed ID: 10482999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft.
    Tarella C; Caracciolo D; Corradini P; Zallio F; Ladetto M; Cuttica A; Rossi G; Novero D; Gavarotti P; Pileri A
    Leukemia; 2000 Apr; 14(4):740-7. PubMed ID: 10764164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL).
    Martín-Henao GA; Picón M; Limón A; Carmona M; Amill B; Azqueta C; López R; González-Barca E; Grañena A; Brunet S; García J
    Bone Marrow Transplant; 1999 Mar; 23(6):579-87. PubMed ID: 10217189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
    Magni M; Di Nicola M; Devizzi L; Matteucci P; Lombardi F; Gandola L; Ravagnani F; Giardini R; Dastoli G; Tarella C; Pileri A; Bonadonna G; Gianni AM
    Blood; 2000 Aug; 96(3):864-9. PubMed ID: 10910898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.
    Corradini P; Astolfi M; Cherasco C; Ladetto M; Voena C; Caracciolo D; Pileri A; Tarella C
    Blood; 1997 Jan; 89(2):724-31. PubMed ID: 9002976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
    Ladetto M; Corradini P; Vallet S; Benedetti F; Vitolo U; Martelli M; Brugiatelli M; Coser P; Perrotti A; Majolino I; Fioritoni G; Morandi S; Musso M; Zambello R; Chisesi T; Di Renzo N; Vivaldi P; De Crescenzo A; Gallamini A; Salvi F; Santini G; Boccomini C; Sorio M; Astolfi M; Drandi D; Pileri A; Tarella C
    Blood; 2002 Sep; 100(5):1559-65. PubMed ID: 12176870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
    Haas R; Moos M; Karcher A; Möhle R; Witt B; Goldschmidt H; Frühauf S; Flentje M; Wannenmacher M; Hunstein W
    J Clin Oncol; 1994 Aug; 12(8):1685-92. PubMed ID: 7518860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E; Fernández de Sevilla A; Domingo-Claros A; Romagosa V; Martín-Henao GA; De Sanjose S; Carmona M; Petit J; García J; Grañena A
    Bone Marrow Transplant; 2000 Nov; 26(10):1051-6. PubMed ID: 11108302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.
    Ogura M; Kagami Y; Suzuki R; Miura K; Uehira K; Kurokawa T; Ito T; Kinoshita T; Emi N; Morishima Y; Kodera Y; Ueda R
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S51-7. PubMed ID: 9272135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
    Lazzarino M; Arcaini L; Bernasconi P; Alessandrino EP; Gargantini L; Cairoli R; Orlandi E; Astori C; Brusamolino E; Pagnucco G; Colombo AA; Calatroni S; Iacona I; Regazzi MB; Morra E
    Br J Haematol; 2002 Jan; 116(1):229-35. PubMed ID: 11841421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.
    Belhadj K; Delfau-Larue MH; Elgnaoui T; Beaujean F; Beaumont JL; Pautas C; Gaillard I; Kirova Y; Allain A; Gaulard P; Farcet JP; Reyes F; Haioun C
    Ann Oncol; 2004 Mar; 15(3):504-10. PubMed ID: 14998857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.
    Ladetto M; Sametti S; Donovan JW; Ferrero D; Astolfi M; Mitterer M; Ricca I; Drandi D; Corradini P; Coser P; Pileri A; Gribben JG; Tarella C
    Exp Hematol; 2001 Feb; 29(2):183-93. PubMed ID: 11166457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
    Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
    Bone Marrow Transplant; 1997 Sep; 20(5):415-20. PubMed ID: 9339759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes.
    Corradini P; Ladetto M; Zallio F; Astolfi M; Rizzo E; Sametti S; Cuttica A; Rosato R; Farina L; Boccadoro M; Benedetti F; Pileri A; Tarella C
    J Clin Oncol; 2004 Apr; 22(8):1460-8. PubMed ID: 15084619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.
    Arcaini L; Orlandi E; Alessandrino EP; Iacona I; Brusamolino E; Bonfichi M; Bernasconi P; Calatroni S; Tenore A; Montanari F; Troletti D; Pascutto C; Regazzi M; Lazzarino M
    Bone Marrow Transplant; 2004 Jul; 34(2):175-9. PubMed ID: 15170171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
    Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
    Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
    Brown JR; Feng Y; Gribben JG; Neuberg D; Fisher DC; Mauch P; Nadler LM; Freedman AS
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1057-65. PubMed ID: 17697968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections.
    Altès A; Sierra J; Esteve J; Martín-Henao G; Marín P; Sureda A; Briones J; Martino R; Villamor N; Colomer D; Carreras E; Garcia J; Brunet S; Montserrat E
    Exp Hematol; 2002 Jul; 30(7):824-30. PubMed ID: 12135682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
    Mohr M; Dalmis F; Hilgenfeld E; Oelmann E; Zühlsdorf M; Kratz-Albers K; Nolte A; Schmitmann C; Onaldi-Mohr D; Cassens U; Serve H; Sibrowski W; Kienast J; Berdel WE
    Clin Cancer Res; 2001 Jan; 7(1):51-7. PubMed ID: 11205918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads.
    Dreger P; von Neuhoff N; Suttorp M; Löffler H; Schmitz N
    Bone Marrow Transplant; 1995 Oct; 16(4):627-9. PubMed ID: 8528184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.